Overweight Clinical Trial
Official title:
Effects of Journaling on Weight Loss
This is a randomized controlled trial with enhanced usual care treatment control. The aim is to determine the effects of journaling and use of resource website on weight loss. There will be two groups of 55 participants each. The intervention condition will be asked to record daily weight, physical activity steps taken and pre-portioned food items and to complete two daily journaling activities. Participants will also receive weekly tracing data, a weekly blog from the principal investigator and have access to a weight control website. The control group will not have access to the tracking, journaling or website for three months. Investigators hypothesize that a website paired with tracking and journaling will be more effective in helping participants lose weight.
Participants will call study line given on recruitment materials and be screened over the
phone.
Baseline visit:
Individuals who meet the screening criteria will be invited to a one-hour training session
about the website and diet plan book. During the training, a coordinator will review the
consent form with the participants and ask if they have any questions. The coordinator will
take consented individuals' height, weight and blood pressure measurements. Participants
will be given a pedometer to use during physical activities and a meal replacement book to
use as a resource.
After baseline visit:
All participants will complete surveys online (Demographics, Three-Factor Eating
Questionnaire, Motivation, Weight Loss Habits, Medication log, International Physical
Activity Questionnaire) and be randomized into one of two groups. The intervention group
will be asked to record their weight, physical activity steps, pre-portioned food items and
journal entries on a daily basis. The control group will be sent an email informing them
they will have access to the tracking, journals and website in three months.
Intervention Group:
Participants will receive daily emails with links to record their weight, physical activity
steps and pre-portioned food items; participants will also complete a journaling response to
two writing prompts. The emails will contain links to the website to be used as a resource.
Every week, participants will enter whether they have an appointment with primary care
provider in the next week. Participants will also receive weekly blogs from the principal
investigator; participants can opt out of receiving the blog emails at any time.
Coordinators will review the database weekly. If a participant has lost ten pounds, they
will be emailed to call their doctor since weight loss can affect blood pressure and
medication needs. If a participant has an upcoming primary care provider appointment, they
will be emailed to print out their tracking graphs (weight, steps taken, meal replacements).
Coordinators will also monitor journal responses; coordinators will contact participants who
wrote useful entries to ask if the participant's responses can be shared with other
participants. Shared posts will be anonymous; only the age of the individual will be given.
Month one and two visits:
Participants from both groups will be asked to come to Hershey Medical Center to have their
height, weight and blood pressure measured.
Month three visit:
Participants from both groups will be asked to come to Hershey Medical Center to have their
height, weight and blood pressure measured. Prior to their visit, participants will be asked
to complete a series of surveys online (Three-Factor Eating Questionnaire, Motivation,
Weight Loss Habits, Medication log, International Physical Activity Questionnaire,
Satisfaction). Participants in the control group will be given a booklet containing the
writing prompts, tracking and website address to complete on their own if they so choose.
Participants will be asked if they would like to come back for an optional video interview.
The interview will consist of six questions about their experience with the study.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Completed |
NCT02899390 -
Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 |